Evidence map›Paper›PMID 33946222›Full record

ArticleBiomolecules2021

Comparison of Anticancer Activity of

Gözde Koygun, Emine Arslan, Gökhan Zengin, Giustino Orlando, Claudio Ferrante

Open access · goldAbstract readComparative Study
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Biosynthesis of ZnONP UsingNanomaterials (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Gözde KoygunDepartment of Nanotechnology and Advanced Materials, Selcuk University, Konya 42130, Turkey.ORCID 0000-0003-1571-2986
Emine ArslanDepartment of Biology, Science Faculty, Selcuk University, Konya 42130, Turkey.
Gökhan ZenginDepartment of Biology, Science Faculty, Selcuk University, Konya 42130, Turkey.ORCID 0000-0001-6548-7823
Giustino OrlandoDepartment of Pharmacy, Università degli Studi "Gabriele d'Annunzio", Via dei Vestini 31, 66100 Chieti, Italy.
Claudio FerranteDepartment of Pharmacy, Università degli Studi "Gabriele d'Annunzio", Via dei Vestini 31, 66100 Chieti, Italy.ORCID 0000-0001-9431-9407
Selçuk University · TRUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicApoptosisBreast NeoplasmsCell AdhesionCell Line, TumorCell ProliferationCell SurvivalFabaceaeFemaleHumansInhibitory Concentration 50MCF-7 CellsPlant ExtractsProto-Oncogene MasAntineoplastic AgentsAntineoplastic Agents, PhytogenicMAS1 protein, humanPlant ExtractsProto-Oncogene MasbioinformaticscancerDorycnium pentaphylluminvasionMCF-12AMCF-7

Identifiers

PMID33946222
PMCPMC8144949
OpenAlexW3159479773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.